Literature DB >> 15255116

Ocular manifestations of mosaic trisomy 22: a case report and review of the literature.

S Thomas1, M Parker, J Tan, D Duckett, G Woodruff.   

Abstract

Mosaic trisomy 22 is rare, but can be compatible with prolonged life. Patients with mosaic trisomy 22 usually present with intrauterine growth retardation, mental retardation, failure to thrive, and craniofacial asymmetry. We report the case of a five-year-old boy who had a birth weight of 3.8 kg and normal developmental milestones. He presented with unilateral ocular manifestations of ptosis, double elevator palsy, high myopia, and choroidal coloboma involving the macula. Cytogenetic evaluation showed a low level of trisomy 22 in peripheral blood lymphocytes (1 in 100) and in cultured fibroblasts from a conjunctival biopsy of the affected eye (1 in 60). Our case demonstrates the value of chromosomal analysis of the tissues involved rather than just karyotyping of the blood lymphocytes to detect mosaicism in patients with localised and unilateral congenital malformations.

Entities:  

Mesh:

Year:  2004        PMID: 15255116     DOI: 10.1076/opge.25.1.53.29004

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  3 in total

1.  [Analysis of an ophthalmic pathology cohort of human fetal eyes with regard to interesting findings].

Authors:  M C Herwig; A M Müller; F G Holz; K U Loeffler
Journal:  Ophthalmologe       Date:  2010-11       Impact factor: 1.059

2.  Mosaic trisomy 22 in a 4-year-old boy with congenital heart disease and general hypotrophy: A case report.

Authors:  Samira Kalayinia; Tina Shahani; Alireza Biglari; Majid Maleki; Hassan Rokni-Zadeh; Zahra Razavi; Nejat Mahdieh
Journal:  J Clin Lab Anal       Date:  2018-09-26       Impact factor: 2.352

Review 3.  Systemic and ocular manifestations of a patient with mosaic ARID1A-associated Coffin-Siris syndrome and review of select mosaic conditions with ophthalmic manifestations.

Authors:  Virginia Miraldi Utz; Diana S Brightman; Monica A Sandoval; Robert B Hufnagel; Howard M Saal
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-09-05       Impact factor: 3.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.